1,3-ditolylguanidine has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bednarski, PJ; Brune, S; Dal Col, V; Korpis, K; Laurini, E; Pricl, S; Schepmann, D; Weber, F; Wünsch, B | 1 |
| Bem, WT; Coscia, CJ; Homan, SM; Johnson, FE; Levy, BK; Mamone, JY; Thomas, GE | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and Benign Neoplasms
| Article | Year |
|---|---|
Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain; Chromatography, Thin Layer; Guinea Pigs; Humans; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Neoplasms; Piperazines; Protein Binding; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Overexpression of sigma receptors in nonneural human tumors.
Topics: Binding, Competitive; Carcinoma; Colonic Neoplasms; Guanidines; Humans; In Vitro Techniques; Kidney Neoplasms; Neoplasms; Piperidines; Receptors, Opioid; Receptors, sigma; Sarcoma | 1991 |